MwanzoBSX • NYSE
add
Boston Scientific Corp
Bei iliyotangulia
$ 95.92
Bei za siku
$ 94.56 - $ 96.69
Bei za mwaka
$ 59.39 - $ 97.13
Thamani ya kampuni katika soko
139.84B USD
Wastani wa hisa zilizouzwa
4.76M
Uwiano wa bei na mapato
78.43
Mgao wa faida
-
Ubadilishanaji wa msingi
NYSE
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 4.21B | 19.34% |
Matumizi ya uendeshaji wa biashara | 2.17B | 20.38% |
Mapato halisi | 469.00M | -7.13% |
Kiwango cha faida halisi | 11.14 | -22.21% |
Mapato kwa kila hisa | 0.63 | 26.00% |
EBITDA | 1.02B | 12.65% |
Asilimia ya kodi ya mapato | 29.90% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 2.50B | 162.82% |
Jumla ya mali | 38.08B | 11.85% |
Jumla ya dhima | 17.12B | 14.80% |
Jumla ya hisa | 20.96B | — |
hisa zilizosalia | 1.47B | — |
Uwiano wa bei na thamani | 6.83 | — |
Faida inayotokana na mali | 4.77% | — |
Faida inayotokana mtaji | 5.63% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | 469.00M | -7.13% |
Pesa kutokana na shughuli | 1.00B | 43.55% |
Pesa kutokana na uwekezaji | -1.43B | -624.37% |
Pesa kutokana na ufadhili | 7.00M | -56.25% |
Mabadiliko halisi ya pesa taslimu | -412.00M | -180.31% |
Mtiririko huru wa pesa | 612.38M | 43.29% |
Kuhusu
Boston Scientific Corporation, headquartered in Marlborough, Massachusetts and incorporated in Delaware, is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. Boston Scientific is widely known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator which they call the EMBLEM subcutaneous implantable defibrillator. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
29 Jun 1979
Makao Makuu
Tovuti
Wafanyakazi
48,000